Intramol 0.005 is a Product of the Generic Timolol Maleate

What Is Intramol 0.005 Indications and Uses?

Timolol Maleate Ophthalmic Solution is indicated in-

Ocular hypertension
Chronic open-angle glaucoma
Aphakic and secondary glaucoma

Pharmacology (Source, Chemical and Physical Composition) Of Intramol 0.005

Timolol Maleate is a beta-adrenoceptor blocking agent; Timolol has the action of reducing elevated intraocular pressure, whether or not accompanied by glaucoma. The action of Timolol is usually rapid, occurring approximately 20 minutes following ocular instillation and maximum effect occurs in one to two hours. Significant lowering of intraocular pressure has been maintained for periods as long as 24 hours with Timolol 0.25% or 0.50%. Unlike miotics, Timolol has practically no effect on pupil size. No change in visual acuity has observed.

Dosage And Administration of Intramol 0.005

The usual starting dose is one drop of 0.25% Timolol in the affected eye twice a day.If the clinical response is not adequate, the dosage may be changed to one drop of 0.50% solution in the affected eye twice a day. Since in some patients the pressure lowering response to Timolol may require a few weeks to stabilize, evaluation should include a determination of intraocular pressure after approximately 4 weeks of treatment with Timolol.If the intraocular pressure is maintained at satisfactory level, the dosage schedule may be changed to one drop once a day. Use in children: Clinical studies in children have not been conducted. Timolol Maleate is not recommended in premature baby and Newborn

Drug Interactions of Intramol 0.005

Beta-blocking agents may lead to hypotension and/or severe bradycardia, and when combined with Timolol Maleate may produce additive effects. Ophthalmic supervision is required in case of concomitant therapy with eye drops containing adrenaline (mydriasis may occur).

Side Effects of Intramol 0.005

Timolol Maleate ophthalmic solution is generally well-tolerated. In clinical studies of Timolol Maleate the adverse reactions reported were mainly:Ocular: symptoms of ocular irritation including conjunctivitis, blepharitis, keratitis, visual disturbances including refractive changes (due to withdrawal of miotics therapy in some cases].Cardiovascular: bradycardia, arrythmia, hypotension, syncope, heart block, cerebro-vascular accident, cerebral ischemia, congestive heart failure, palpitation, cardiac arrest.Respiratory: bronchospasm, respiratory failure and dyspnea.Systemic: headache, nausea, dizziness, depression, fatigue.

Use During Pregnancy and Lactation

Timolol Maleate has not yet been studied in human pregnancy.

Precautions And Warnings for Intramol 0.005

Patients with inadequate cardiac function, DM, myasthenia gravis, cerebrovascular insufficiency, history of atopy. Avoid abrupt withdrawal as it may exacerbate angina symptoms or precipitate MI in patients with coronary artery disease, or precipitate thyroid crisis in patients with thyrotoxicosis. Patients undergoing major surgery. May mask signs of hyperthyroidism and hypoglycaemia. Ophth soln should not be used as monotherapy for angle-closure glaucoma. Renal and hepatic impairment. Pregnancy and lactation.

Therapeutic Class

Drugs for miotics and glaucoma

Storage Conditions of It

The drug is to be used within 30 days after first opening. Store at 15°-25°C. Protect from light. The bottle is to be closed strongly immediately after use. keep out of reach of children.